ArticleACS omega2023
Synthesis and Characterization of a Novel DOPO-Based Flame Retardant Intermediate and Its Flame Retardancy as a Polystyrene Intrinsic Flame Retardant.
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The research on intrinsic flame retardant has become a hot topic in the field of flame retardant. The synthesis of reactive flame-retardant monomer is one of the effective methods to obtain an intrinsic flame retardant. In addition, in view of the small molecular flame retardant easily migrates from the polymer during the use process, which leads to the gradual reduction of the flame retardant effect and even the gradual loss of flame retardant performance, and the advantages of atom transfer radical polymerization (ATRP) technology in polymer structure design and function customization, we first synthesized reactive flame retardant monomer 6-(hydroxymethyl)dibenzo[c,e][1,2]oxaphosphinine 6-oxide (FAA-DOPO), then synthesized polystyrene bromine (PS
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.